Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FEMPM
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $24,357
Award facts
- Contract value 100% obligated
- $24,357.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $24,357 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois. This delivery order, issued on December 12, 2025, is part of DMS Pharmaceutical Group's broader engagement under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative. The award carries no set-aside designation, reflecting the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will serve as the sole contractor on this delivery order with no identified subcontractors involved.
This delivery order authorizes DMS Pharmaceutical Group to supply pharmaceutical products and medical consumables to support Department of Defense healthcare operations, drawing from its comprehensive product portfolio that includes branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and over-the-counter drugs. The company's selection is supported by its established performance as a prime vendor under the PPV-G GEN V contract framework, a $30.3 billion DLA acquisition strategy designed to ensure reliable pharmaceutical supply chains for military medical facilities worldwide. The ultimate completion date for this specific delivery order is December 15, 2025, with DMS Pharmaceutical Group positioned to fulfill diverse and specialized pharmaceutical requirements across the federal military medical system.
Quick answers
Who was awarded contract SPE2DU26FEMPM?
SPE2DU26FEMPM was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 12, 2025.
How much is contract SPE2DU26FEMPM worth?
The government has obligated $24,357 on SPE2DU26FEMPM.
Is contract SPE2DU26FEMPM an order under another contract?
Yes. SPE2DU26FEMPM is a delivery order under SPE2DU25D9517, an indefinite delivery contract.
Was contract SPE2DU26FEMPM competed?
The extent of competition for SPE2DU26FEMPM was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award